Introduction
Oriahnn is an oral hormonal treatment specifically approved to manage heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Oriahnn contains elagolix, estradiol, and norethindrone acetate. Elagolix reduces ovarian hormone production, while the estrogen and progestin components provide hormonal support as part of the treatment regimen.
Oriahnn can be an effective option for reducing heavy menstrual blood loss. However, it is intended for limited use because continued treatment can reduce bone mineral density. Treatment is limited to 24 months.
For patients concerned about the cost of Oriahnn, patient assistance programs may provide options for improving medication affordability. Prescription Hope helps eligible patients navigate prescription assistance and medication access options.
What Is A Patient Assistance Program?
Understanding Oriahnn Prescription Assistance
Unfortunately, the cost of brand-name medications continues to rise without warning. Patients needing medication like Oriahnn but who don’t have adequate insurance coverage may struggle to get their medication at affordable rates.
Pharmaceutical manufacturers understand this and often offer patient assistance programs as a solution.
Qualified patients can access their brand-name medication at affordable rates through the manufacturer’s patient assistance program.
However, patient assistance programs have a reputation for including difficult application processes that can overwhelm and discourage patients attempting to apply on their own.
Prescription Hope offers a solution.
How Expert Advocates Help Make Oriahnn More Affordable
Personalized Medication Assistance
Prescription Hope can provide fibroid medication assistance services offering support and advocacy on the patient’s behalf throughout the application process.
Our team of patient advocates handles forms, documents, and signatures, coordinating with healthcare providers and manufacturers, and navigating any bureaucratic red tape that can come with patient assistance programs.
Ongoing Patient Support
Once a patient is approved for Oriahnn access, we continue to manage the administrative tasks required by the manufacturer to maintain enrollment status.
Our team manages refill scheduling, document updates, issue resolution, yearly renewals, and more.
Oriahnn Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Treatment Costs
Patients needing medication cost reduction through prescription assistance services may benefit from enrolling with Prescription Hope. Our service rate is a simple $70.00 per month, per medication.
And if we cannot help a patient save, then they pay nothing!
Oriahnn Patient Assistance Eligibility
General Eligibility Requirements
Patient assistance program requirements often fall into several categories. These include:
Income: Income range is an important criterion used for qualification purposes.
Insurance: Each program determines insurance coverage status for qualification.
Prescription: All qualified patients must have a valid prescription for their intended brand-name medication.
Residency: All qualified patients must be legal U.S. residents.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Those looking to enroll in the Oriahnn patient assistance program should enroll through Prescription Hope. Our 6-step process is:
- Submit Information: Patients can fill out our online enrollment form in minutes.
- Advocate Contact: Once we receive your completed enrollment form, our team will contact you within 1-2 business days.
- Document Collection: After prequalification, a patient advocate will collect all documents needed for your application.
- Provider Coordination: Our team will contact your healthcare provider to secure needed signatures.
- Program Submission: Once everything is prepared, our team submits your application and follows up with the manufacturer throughout the process.
- Medication Delivery: Following approval, qualified patients typically receive their medication within 2 weeks. All medications ship directly from the manufacturer to the qualified patient’s door or doctor’s office.
Prescription Hope is not a pharmacy or manufacturer and therefore does not handle medication at any time.
Understanding Oriahnn
How Oriahnn Works
Oriahnn combines elagolix, estradiol, and norethindrone acetate, which work together to manage heavy menstrual bleeding associated with uterine fibroids.
Elagolix is a GnRH receptor antagonist. It blocks GnRH signaling at the pituitary gland, reducing the release of luteinizing hormone and follicle-stimulating hormone. This lowers ovarian production of estradiol and progesterone.
The estradiol component provides a low dose of estrogen, while norethindrone acetate is a progestin included as part of the hormonal regimen.
Together, these ingredients reduce the ovarian hormone activity associated with fibroid-related heavy menstrual bleeding while providing low-dose estrogen and progestin as part of the treatment.
What Conditions Does Oriahnn Treat?
Oriahnn is FDA-approved for the management of heavy menstrual bleeding associated with uterine leiomyomas, commonly called uterine fibroids, in premenopausal women.
Uterine fibroids are noncancerous growths that develop in or around the uterus. They can cause heavy or prolonged menstrual bleeding and may contribute to anemia.
It is intended to manage the heavy bleeding associated with fibroids. It is not approved to eliminate or permanently cure uterine fibroids.
Treatment is limited to 24 months because of the risk of bone mineral density loss. Safety and effectiveness have not been established in pediatric patients.
Benefits of Treatment
For appropriately selected premenopausal women with fibroid-associated heavy menstrual bleeding, Oriahnn may:
- Substantially reduce menstrual blood loss
- Help control heavy or prolonged bleeding
- Improve anemia associated with heavy menstrual blood loss
- Reduce the daily burden associated with heavy menstrual bleeding
- Provide an oral treatment option for fibroid-related bleeding
In the two pivotal studies, 68.5% and 76.5% of women receiving Oriahnn achieved the study-defined treatment response, compared with 8.7% and 10.5% receiving placebo.
Among women who were anemic at baseline, more Oriahnn-treated patients achieved an increase in hemoglobin of more than 2 g/dL at Month 6 compared with placebo.
Clinical-trial outcomes demonstrate efficacy in the studied population but do not guarantee an individual patient’s response.
Important Safety Information and Side Effects
Oriahnn carries an FDA Boxed Warning for thromboembolic disorders and vascular events. Estrogen-and-progestin combinations can increase the risk of serious blood clots, stroke, and heart attack.
Blood Clots and Cardiovascular Events
Important risks include:
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
- Stroke
- Myocardial infarction
Risk may be greater in women with factors such as smoking, age over 35, uncontrolled hypertension, dyslipidemia, vascular disease, or obesity.
This specific medication should be discontinued if an arterial or venous thrombotic, cardiovascular, or cerebrovascular event occurs or is suspected.
Bone Loss
Oriahnn can reduce bone mineral density, and bone loss may not be completely reversible after treatment ends.
Important considerations include:
- Treatment is limited to 24 months
- Bone-health risk should be assessed before treatment
- Baseline DXA bone-density testing is recommended
- BMD may be reassessed during treatment
- It is contraindicated in women with known osteoporosis
Hormonally Sensitive Malignancies
Oriahnn is contraindicated in women with current or previous breast cancer or other specified hormonally sensitive malignancies and in women at increased risk for certain hormonally sensitive malignancies.
Mood Changes
Reported mood-related effects include:
- Depression
- Depressed mood
- Tearfulness
- Anxiety
- Other mood changes
- Suicidal thoughts or behavior
New or worsening depression or significant mood changes should be promptly reported to a healthcare provider.
Liver Effects
Oriahnn is contraindicated in women with known hepatic impairment or liver disease.
Patients should seek medical attention for symptoms that may indicate liver injury, including yellowing of the skin or eyes.
Increased Blood Pressure
This medication can increase blood pressure and is contraindicated in women with uncontrolled hypertension.
Blood pressure should be monitored during treatment.
Metabolic Effects
Oriahnn may affect:
- Blood glucose
- Total cholesterol
- LDL cholesterol
- HDL cholesterol
- Triglycerides
Women with diabetes, prediabetes, or lipid abnormalities may require appropriate monitoring.
Changes in Menstrual Bleeding
Oriahnn can reduce or stop menstrual bleeding, which may make pregnancy more difficult to recognize.
This medication does not prevent pregnancy.
Non-hormonal contraception should be used during treatment and for 28 days after discontinuation.
Common Side Effects
The most common adverse reactions occurring more frequently with Oriahnn than placebo include:
- Hot flashes
- Headache
- Fatigue
- Metrorrhagia
Other reported adverse reactions include:
- Decreased libido
- Joint pain
- Increased blood pressure
- Hair loss
- Mood swings
- Influenza
- Abdominal bloating or distension
- Upper respiratory tract infection
- Heavy menstrual bleeding
- Vomiting
- Weight gain
Other Important Safety Considerations
Oriahnn is contraindicated in women with certain thromboembolic conditions, pregnancy, known osteoporosis, specified hormonally sensitive malignancies, hepatic impairment or liver disease, undiagnosed abnormal uterine bleeding, and severe hypersensitivity to the medication.
The morning capsule also contains FD&C Yellow No. 5 (tartrazine), which can cause allergic-type reactions in susceptible individuals.
Access to Multiple Medications
Support Beyond Oriahnn
Some patients who need women’s health medication assistance may need financial assistance with other brand-name medications.
With a list of hundreds of available meds, Prescription Hope often helps qualified patients access multiple patient assistance programs.
No matter how many you qualify for, our service fee remains a simple $70.00 per month, per medication.
Why Choose Prescription Hope for Medication Assistance
Patient-Focused Medication Support
For 20 years, Americans across the nation have trusted Prescription Hope’s patient-focused medication assistance services. Our team is dedicated to providing compassionate support and advocacy throughout the application process and beyond.
Simplified Access to Specialty Therapies
To get Oriahnn assistance, qualified patients need only enroll through Prescription Hope. To determine whether you qualify for Oriahnn specifically, simply enroll with Prescription Hope risk-free.
Ongoing Prescription Assistance
Those needing help paying for Oriahnn may benefit from Prescription Hope’s advocacy and support services.
Not only does Prescription Hope help throughout the application process, but our team continues to support patients throughout their medication access journey.
If you need access to affordable Oriahnn, then be sure to enroll with Prescription Hope to find out how we can help you save today!